Monte Rosa Therapeutics, Inc. (GLUE)
14.22
+0.28
(+2.01%)
USD |
NASDAQ |
Sep 01, 12:00
Monte Rosa Therapeutics Cash from Operations (TTM) : -24.07M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.07M |
| March 31, 2026 | -14.68M |
| December 31, 2025 | -22.80M |
| September 30, 2025 | 149.14M |
| June 30, 2025 | 27.72M |
| March 31, 2025 | 34.67M |
| December 31, 2024 | 42.00M |
| September 30, 2024 | -57.29M |
| June 30, 2024 | -61.00M |
| March 31, 2024 | -58.56M |
| December 31, 2023 | -43.80M |
| Date | Value |
|---|---|
| September 30, 2023 | -97.40M |
| June 30, 2023 | -93.29M |
| March 31, 2023 | -88.47M |
| December 31, 2022 | -92.47M |
| September 30, 2022 | -82.68M |
| June 30, 2022 | -79.87M |
| March 31, 2022 | -72.95M |
| December 31, 2021 | -59.36M |
| September 30, 2021 | -53.76M |
| June 30, 2021 | -42.86M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Nurix Therapeutics, Inc. | -293.70M |
| Gilead Sciences, Inc. | 13.55B |
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Capricor Therapeutics, Inc. | -104.00M |
| Cue Biopharma, Inc. | -50.05M |